Bis-Benzimidazole Hits against Naegleria fowleri Discovered with New High-Throughput Screens |
| |
| Authors: | Christopher A Rice Beatrice L Colon Mehmet Alp Hakan G?ker David W Boykin Dennis E Kyle |
| |
| Institution: | aDepartment of Global Health, College of Public Health, University of South Florida, Tampa, Florida, USA;bMorsani College of Medicine, University of South Florida, Tampa, Florida, USA;cDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Ankara University, Tandogan, Ankara, Turkey;dDepartment of Chemistry, Georgia State University, Atlanta, Georgia, USA |
| |
| Abstract: | Naegleria fowleri is a pathogenic free-living amoeba (FLA) that causes an acute fatal disease known as primary amoebic meningoencephalitis (PAM). The major problem for infections with any pathogenic FLA is a lack of effective therapeutics, since PAM has a case mortality rate approaching 99%. Clearly, new drugs that are potent and have rapid onset of action are needed to enhance the treatment regimens for PAM. Diamidines have demonstrated potency against multiple pathogens, including FLA, and are known to cross the blood-brain barrier to cure other protozoan diseases of the central nervous system. Therefore, amidino derivatives serve as an important chemotype for discovery of new drugs. In this study, we validated two new in vitro assays suitable for medium- or high-throughput drug discovery and used these for N. fowleri. We next screened over 150 amidino derivatives of multiple structural classes and identified two hit series with nM potency that are suitable for further lead optimization as new drugs for this neglected disease. These include both mono- and diamidino derivatives, with the most potent compound (DB173) having a 50% inhibitory concentration (IC50) of 177 nM. Similarly, we identified 10 additional analogues with IC50s of <1 μM, with many of these having reasonable selectivity indices. The most potent hits were >500 times more potent than pentamidine. In summary, the mono- and diamidino derivatives offer potential for lead optimization to develop new drugs to treat central nervous system infections with N. fowleri. |
| |
| Keywords: | |
|
|
